Personalized Treatment of Lymphoid Cancer: British Columbia as Model Province

Corey Casper

Treatment Outcomes and Survival After a Diagnosis of Endemic Burkitt Lymphoma in Uganda

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Richard Lock

Transcriptional and epigenetic control of innate-like T lymphocyte development

Non-Hodgkin lymphoma Hodgkin lymphoma

Robert S Negrin

Bone Marrow Grafting for Leukemia and Lymphoma

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Laura Pasqualucci

Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Investigator from French National Centre for Scientific Research (CNRS)

Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma

Non-Hodgkin lymphoma

Pathology

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Ulf Klein

The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis

Non-Hodgkin lymphoma Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Henry Ddungu

The Optimal Use of Platelet Support Transfusion Among Patients with Hematological Malignancies in Uganda

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

John L. Cleveland

Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis

Non-Hodgkin lymphoma Hodgkin lymphoma